The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2021 | ASCO GI 2021: biomarker-driven research, radiomics & CAR-T
Heinz-Josef Lenz, MD, FACP, University of Southern California, Los Angeles, CA, provides a summary of key data presented at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium including the influx of biomarker-driven research as well as discussions on the role of digital pathology and radiomics. The potential of CAR T-cell therapies in colorectal cancer is also discussed by Prof. Lenz. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
